Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine

This publication has 28 references indexed in Scilit:

• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results
  European Journal of Clinical Microbiology & Infectious Diseases, 1994
• MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
  Cell, 1994
• Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma
  Nature, 1993
• The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.
  Journal of Clinical Investigation, 1992
• Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.
  The Journal of Experimental Medicine, 1992
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991
• Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells.
  The Journal of Experimental Medicine, 1990
• Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.
  Journal of Clinical Investigation, 1990
• Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.
  The Journal of Experimental Medicine, 1987